MTOR and neoplasm: Lysates of tumours from each independent experiment showed consistent reduction of the PI3K–mTOR–AKT pathway biomarkers pAKT, pS6 and pNDRG1 at 2 and 6 h after treatment with AZD2014 (Fig. 1A).